VIEWPOINTS PharmaShots Interview: Coral Genomics’s Atray Dixit Shares Insights on the 2021 Innovation Challenge in Inflammatory Bowel DiseaseBySenior EditorDecember 7, 20210Comments
VIEWPOINTS PharmaShots Interview: Medidata’s Ben Schlatka Shares Insights on Agreement with Labcorp to Advance the Use of Medical-Grade SensorsBySenior EditorDecember 6, 20210Comments
VIEWPOINTS PharmaShots Interview: Cartesian Therapeutics’s Dr. Murat Kalayoglu Shares Insight on RNA Cell Therapy for an Autoimmune DiseaseBySenior EditorDecember 1, 20210Comments
VIEWPOINTS PharmaShots Interview: Vivacare’s Mark Becker Shares Insight on the Digital Patient Education Service for Allergic ConditionsBySenior EditorNovember 30, 20210Comments
VIEWPOINTS PharmaShots Interview: Guardant Health’s Kathryn Lang Shares Insight on the Data of Guardant360 Liquid Biopsy Test for the Treatment of Advanced Non-Small Cell Lung CancerBySenior EditorNovember 29, 20210Comments
VIEWPOINTS PharmaShots Interview: Janssen’s Jan Wehkamp Shares Insight on the Data of Stelara (ustekinumab) for IBD and other Approved Indications and Presented 13 Abstracts at UEGWBySenior EditorNovember 24, 20210Comments
VIEWPOINTS PharmaShots Interview: ProQR’s Daniel A. de Boer Shares Insight on Sepofarsen for the Treatment of Leber Congenital Amaurosis (LCA10)BySenior EditorNovember 23, 20210Comments
